BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 26279835)

  • 1. Hypo-endemic onchocerciasis hotspots: defining areas of high risk through micro-mapping and environmental delineation.
    Kelly-Hope LA; Unnasch TR; Stanton MC; Molyneux DH
    Infect Dis Poverty; 2015; 4():36. PubMed ID: 26279835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loa loa vectors Chrysops spp.: perspectives on research, distribution, bionomics, and implications for elimination of lymphatic filariasis and onchocerciasis.
    Kelly-Hope L; Paulo R; Thomas B; Brito M; Unnasch TR; Molyneux D
    Parasit Vectors; 2017 Apr; 10(1):172. PubMed ID: 28381279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid integrated clinical survey to determine prevalence and co-distribution patterns of lymphatic filariasis and onchocerciasis in a
    Brito M; Paulo R; Van-Dunem P; Martins A; Unnasch TR; Novak RJ; Jacob B; Stanton MC; Molyneux DH; Kelly-Hope LA
    Parasite Epidemiol Control; 2017 Aug; 2(3):71-84. PubMed ID: 29774284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying co-endemic areas for major filarial infections in sub-Saharan Africa: seeking synergies and preventing severe adverse events during mass drug administration campaigns.
    Cano J; Basáñez MG; O'Hanlon SJ; Tekle AH; Wanji S; Zouré HG; Rebollo MP; Pullan RL
    Parasit Vectors; 2018 Jan; 11(1):70. PubMed ID: 29382363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental factors associated with the distribution of Loa loa vectors Chrysops spp. in Central and West Africa: seeing the forest for the trees.
    Badia-Rius X; Betts H; Molyneux DH; Kelly-Hope LA
    Parasit Vectors; 2019 Feb; 12(1):72. PubMed ID: 30728063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Satellite mapping of Loa loa prevalence in relation to ivermectin use in west and central Africa.
    Thomson MC; Obsomer V; Dunne M; Connor SJ; Molyneux DH
    Lancet; 2000 Sep; 356(9235):1077-8. PubMed ID: 11009145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing evidence of low lymphatic filariasis prevalence in high risk Loa loa areas in Central and West Africa: a literature review.
    Kelly-Hope LA; Hemingway J; Taylor MJ; Molyneux DH
    Parasit Vectors; 2018 Jun; 11(1):349. PubMed ID: 29907117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment and monitoring of onchocerciasis in Latin America.
    Rodríguez-Pérez MA; Unnasch TR; Real-Najarro O
    Adv Parasitol; 2011; 77():175-226. PubMed ID: 22137585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
    Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Projected Number of People With Onchocerciasis-Loiasis Coinfection in Africa, 1995 to 2025.
    Vinkeles Melchers NVS; Coffeng LE; Boussinesq M; Pedrique B; Pion SDS; Tekle AH; Zouré HGM; Wanji S; Remme JH; Stolk WA
    Clin Infect Dis; 2020 May; 70(11):2281-2289. PubMed ID: 31304961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated rapid mapping of onchocerciasis and loiasis in the Democratic Republic of Congo: impact on control strategies.
    Tekle AH; Zoure H; Wanji S; Leak S; Noma M; Remme JH; Amazigo U
    Acta Trop; 2011 Sep; 120 Suppl 1():S81-90. PubMed ID: 20525531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
    Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
    Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of Onchocerciasis Elimination Using a "Test-and-not-treat" Strategy in Loa loa Co-endemic Areas.
    Blok DJ; Kamgno J; Pion SD; Nana-Djeunga HC; Niamsi-Emalio Y; Chesnais CB; Mackenzie CD; Klion AD; Fletcher DA; Nutman TB; de Vlas SJ; Boussinesq M; Stolk WA
    Clin Infect Dis; 2021 Jun; 72(12):e1047-e1055. PubMed ID: 33289025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
    Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon.
    Wanji S; Tendongfor N; Esum M; Yundze SS; Taylor MJ; Enyong P
    Filaria J; 2005 Apr; 4(1):2. PubMed ID: 15817124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reaching the last mile: main challenges relating to and recommendations to accelerate onchocerciasis elimination in Africa.
    Gebrezgabiher G; Mekonnen Z; Yewhalaw D; Hailu A
    Infect Dis Poverty; 2019 Jul; 8(1):60. PubMed ID: 31269966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection.
    Boussinesq M; Gardon J
    Ann Trop Med Parasitol; 1997 Sep; 91(6):573-89. PubMed ID: 9425360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innovative tools for assessing risks for severe adverse events in areas of overlapping Loa loa and other filarial distributions: the application of micro-stratification mapping.
    Kelly-Hope LA; Cano J; Stanton MC; Bockarie MJ; Molyneux DH
    Parasit Vectors; 2014 Jul; 7():307. PubMed ID: 24992829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preparatory phase for ground larviciding implementation for chocerciasis control in the Meme River Basin in South West Cameroon: the COUNTDOWN Consortium alternative strategy implementation trial.
    Ekanya R; Obie ED; Hamill L; Thorogood S; Abong RA; Njouendou AJ; Amuam A; Ndzeshang BL; Nkimbeng DA; Cho JF; Esum ME; Enyong P; Turner JD; Taylor MJ; Wanji S
    Parasit Vectors; 2022 Jun; 15(1):219. PubMed ID: 35729597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization and evaluation of the Esperanza Window Trap to reduce biting rates of Simulium damnosum sensu lato in Northern Uganda.
    Loum D; Cozart D; Lakwo T; Habomugisha P; Jacob B; Cupp EW; Unnasch TR
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007558. PubMed ID: 31310607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.